Winston Medical Supply Co., Ltd. (6817.TWO)
- Previous Close
128.50 - Open
129.00 - Bid --
- Ask --
- Day's Range
125.50 - 129.00 - 52 Week Range
75.90 - 145.00 - Volume
46,042 - Avg. Volume
108,652 - Market Cap (intraday)
2.376B - Beta (5Y Monthly) 0.11
- PE Ratio (TTM)
15.03 - EPS (TTM)
8.58 - Earnings Date --
- Forward Dividend & Yield 5.00 (3.91%)
- Ex-Dividend Date Jul 6, 2023
- 1y Target Est
--
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products. It offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations, which are in oral dosage forms, such as powders, troches, tables, film coated tablets, chewables, and capsules for the treatment of colds, gastrointestinal issues, or other indications. The company was founded in 1974 and is based in Tainan City, Taiwan. Winston Medical Supply Co., Ltd. is a subsidiary of Medigen Biotechnology Corp.
www.winston.com.tw--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 6817.TWO
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6817.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6817.TWO
Valuation Measures
Market Cap
2.36B
Enterprise Value
2.17B
Trailing P/E
14.92
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.34
Price/Book (mrq)
5.51
Enterprise Value/Revenue
3.05
Enterprise Value/EBITDA
9.48
Financial Highlights
Profitability and Income Statement
Profit Margin
22.39%
Return on Assets (ttm)
16.31%
Return on Equity (ttm)
40.21%
Revenue (ttm)
709.07M
Net Income Avi to Common (ttm)
158.76M
Diluted EPS (ttm)
8.58
Balance Sheet and Cash Flow
Total Cash (mrq)
299.14M
Total Debt/Equity (mrq)
14.94%
Levered Free Cash Flow (ttm)
158.05M
Company Insights: 6817.TWO
6817.TWO does not have Company Insights